{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:20:35Z","timestamp":1760523635823},"reference-count":7,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.1001\/jamadermatol.2018.1667","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T18:26:59Z","timestamp":1530642419000},"page":"997","source":"Crossref","is-referenced-by-count":5,"title":["Prescription to Over-the-Counter Switch of Metronidazole and Azelaic Acid for Treatment of Rosacea"],"prefix":"10.1001","volume":"154","author":[{"given":"Jean S.","family":"McGee","sequence":"first","affiliation":[{"name":"Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan K.","family":"Wilkin","sequence":"additional","affiliation":[{"name":"Retired, Columbus, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"5","key":"dvp180007r1","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/bjd.2006.155.issue-5","article-title":"Poor agreement between self-reported and dermatologists\u2019 diagnoses for five common dermatoses.","volume":"155","author":"Jagou","year":"2006","journal-title":"Br J Dermatol"},{"issue":"4","key":"dvp180007r2","first-page":"40","article-title":"Self-diagnosis of mild-to-moderate acne for self-treatment with blue light therapy.","volume":"2","author":"Gold","year":"2009","journal-title":"J Clin Aesthet Dermatol"},{"issue":"7","key":"dvp180007r7","doi-asserted-by":"crossref","first-page":"13030\/qt4nc3p4q2","DOI":"10.5070\/D3227031660","article-title":"Most people with psoriasis or rosacea are not being treated.","volume":"22","author":"Wehausen","year":"2016","journal-title":"Dermatol Online J"},{"key":"dvp180007r3","author":"FDA Nonprescription Drugs Advisory Committee","year":"2016"},{"key":"dvp180007r4","unstructured":"Galderma Laboratories (2010). METROGEL (metronidazole) gel, 1%: highlights of prescribing information. https:\/\/www.accessdata.fda.gov. Accessed April 5, 2018."},{"key":"dvp180007r5","unstructured":"Intendis Inc (2010). Finacea (azelaic acid) gel, 15%: highlights of prescribing information. https:\/\/www.accessdata.fda.gov. Accessed April 5, 2018."},{"key":"dvp180007r6","unstructured":"Consumer Healthcare Products Association (2018). Rx-to-OTC Switch. https:\/\/www.chpa.org\/Switch.aspx. Accessed April 5, 2018."}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2686156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T22:54:10Z","timestamp":1661554450000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2018.1667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":7,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2018.1667","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,1]]}}}